REGEN-COV (EUA) (casirivimab (regn10933)/imdevimab (regn10987))


Drug overview for REGEN-COV (EUA) (casirivimab (regn10933)/imdevimab (regn10987)):

Generic name: casirivimab (REGN10933)/imdevimab (REGN10987)
Drug class:
Therapeutic class:

No enhanced Introduction information available for this drug.

 No enhanced Uses information available for this drug.
DRUG IMAGES
  • No Image Available
    No Image Available
The following indications for REGEN-COV (EUA) (casirivimab (regn10933)/imdevimab (regn10987)) have been approved by the FDA:

Indications:
None.

Professional Synonyms:
None.